Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial

BACKGROUND: Stocks of yellow fever vaccine are insufficient to cover exceptional demands for outbreak response. Fractional dosing has shown efficacy, but evidence is limited to the 17DD substrain vaccine. We assessed the immunogenicity and safety of one-fifth fractional dose compared with standard d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet
Main Authors: Juan-Giner, Aitana, Kimathi, Derick, Grantz, Kyra H, Hamaluba, Mainga, Kazooba, Patrick, Njuguna, Patricia, Fall, Gamou, Dia, Moussa, Bob, Ndeye S, Monath, Thomas P, Barrett, Alan D, Hombach, Joachim, Mulogo, Edgar M, Ampeire, Immaculate, Karanja, Henry K, Nyehangane, Dan, Mwanga-Amumpaire, Juliet, Cummings, Derek A T, Bejon, Philip, Warimwe, George M, Grais, Rebecca F
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794660/
https://ncbi.nlm.nih.gov/pubmed/33422245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(20)32520-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados